NCT02733042 · Interventional trial
A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia
Overall registry status Completed
Phase 1 · Phase 2
Conditions Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma
Delaware Valley sites
- Jefferson Medical Oncology Associates · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory